°Ç¿° Ä¡·á ½ÃÀå Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : Ä¡·á¹ýº°, Áõ»óº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2032³â)
Tendonitis Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment (Therapy and Surgery); By Condition; By Region; Segment Forecast, 2023-2032
»óǰÄÚµå : 1338939
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2023³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 114 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 5,908,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,299,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,689,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è °Ç¿° Ä¡·á ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 2,916¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¿©·¯ Á¾·ùÀÇ ½ºÆ÷Ã÷ °ü·Ã ºÎ»óÀÇ Áõ°¡, ½ÅÁ¦Ç° ¹× ½Å±â¼úÀÇ ²÷ÀÓ¾ø´Â Çõ½Å, ȸº¹ ½Ã°£À» ´ÜÃàÇÏ°í ´õ ³ªÀº Ä¡·á ½Ã¼³À» Á¦°øÇÏ´Â Ä¡·á¹ý, ±×¸®°í Àü ¼¼°è Á¤ºÎ ±â°üÀÇ ³ë·Â È®´ë´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, Á¤Çü¿Ü°ú ¼ö¼úÀÇ ³ôÀº º¸±Þ·ü, È®¸³µÈ ÀÇ·á ÀÎÇÁ¶ó¿Í Ä¡·á ½Ã¼³ÀÇ Á¸Àç, ÁÖ¿ä ±â¾÷µéÀÇ Á¦Ç° Æ÷Æ®Æú¸®¿À È®´ë ½ÃÇàÀº ¼¼°è ½ÃÀåÀ» ´õ¿í ºü¸¥ ¼Óµµ·Î ÀÚ±ØÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 11¿ù Ä·¹ö Á¦¾àÀº ½ÅÁ¦Ç° "Naproxen Oral Suspension"À» Ãß°¡Çß½À´Ï´Ù. »õ·Î °³¹ßµÈ ÀÌ Á¦Ç°Àº °Ç¿° Áõ»ó Ä¡·á¿¡ ÀûÀÀÁõÀ» °¡Áö°í ÀÖ½À´Ï´Ù.

Àü ¼¼°è ȯÀÚµéÀº ´Ù¿îŸÀÓÀ» ÃÖ¼ÒÈ­Çϰí ȸº¹ ½Ã°£À» ´ÜÃàÇÒ ¼ö ÀÖ´Â ºñħ½ÀÀû Ä¡·á¹ýÀ» ã°í ÀÖÀ¸¸ç, ÀÌ´Â ¹°¸®Ä¡·á, ÃÊÀ½ÆÄ Ä¡·á, Ãæ°ÝÆÄ Ä¡·á¿Í °°Àº Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÈûÁÙ ´ëü ¹× Àç»ý ±â¼úÀÇ ²÷ÀÓ¾ø´Â Çõ½ÅÀº ´ëü Àΰø Á¶Á÷¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇÏ¿© ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ȯÀÚÀÇ Ç÷¼ÒÆÇÀ» ȯºÎÀÇ ÈûÁÙ¿¡ ÁÖÀÔÇÏ¿© Á¶Á÷ ȸº¹À» ÃËÁøÇÏ¿© Ä¡À¯¸¦ ÃËÁøÇÏ´Â »õ·Î¿î Á¾·ùÀÇ Ä¡·á¹ýÀÇ º¸±Þ·üÀÌ Å©°Ô Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ Ä¡·á¹ýÀº ÆÈ²ÞÄ¡, ¾î±ú, ¹«¸­ÀÇ °Ç¿° Ä¡·á¿¡ À¯¸ÁÇÑ Ä¡·á¹ýÀ¸·Î Àü ¼¼°èÀûÀ¸·Î Å« Àαâ¿Í °ßÀηÂÀ» ¾ò°í ÀÖ½À´Ï´Ù.

ÀÌ ¿Ü¿¡µµ ÀÇ·á ±â¼úÀÇ ±Þ¼ÓÇÑ ¹ßÀü°ú ÇÔ²² ¾à¹°, ¹°¸®Ä¡·á, ¼ö¼ú µî ´Ù¾çÇÑ Á¾·ùÀÇ Çõ½ÅÀûÀÎ °Ç¿° Ä¡·á¹ýÀÌ Àü ¼¼°èÀûÀ¸·Î »ç¿ë °¡´ÉÇØÁö¸é¼­ Ä¡·áÀÇ È¿°ú¿Í È¿À²¼ºÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ±×·³¿¡µµ ºÒ±¸Çϰí Á¶±â Áø´ÜÀÇ Á߿伺¿¡ ´ëÇÑ Àνİú º¸±ÞÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå¿¡ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

°Ç¿° Ä¡·á ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

2022³â ½ÃÀå Á¡À¯À²Àº ¹°¸®Ä¡·á ºÐ¾ß°¡ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇߴµ¥, ÀÌ´Â ÁַΠȯÀÚ¸¦ ¾È½É½Ãų ¼ö ÀÖ´Â ´É·Â°ú ºñ¿ë È¿À²ÀûÀÎ ¿É¼ÇÀ¸·Î Àα⸦ ²ø¸é¼­ ¹°¸®Ä¡·áÀÇ Ã¤ÅÃÀÌ Áõ°¡Ç߱⠶§¹®ÀÔ´Ï´Ù.

°ñÆÛ ÆÈ²ÞÄ¡ ºÐ¾ß´Â »ç¶÷µéÀÇ ¶óÀÌÇÁ½ºÅ¸ÀÏÀÌ ²÷ÀÓ¾øÀÌ º¯È­ÇÏ°í ½ºÆ÷Ã÷ Ȱµ¿¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì Áö¿ªÀº »ç¶÷µéÀÇ ¼Òºñ ´É·Â Áõ°¡, Àß Á¤ºñµÈ ÀÎÇÁ¶ó, ÀÇ·á ±â¼ú ±â¾÷°úÀÇ Çù¾÷¿¡ ´ëÇÑ ³ôÀº º¸±Þ·ü·Î ÀÎÇØ 2022³â ¼¼°è ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ÁÖ¿ä ½ÃÀå ±â¾÷Àº Almatica Pharma, Teva Pharmaceuticals Industries, Abbott Laboratories, Stryker Corporation, Ingelheim Pharmaceuticals, Zimmer Biomet Holdings µîÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ °Ç¿° Ä¡·á ½ÃÀå¿¡ °üÇÑ ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ °Ç¿° Ä¡·á ½ÃÀå, Ä¡·áº°

Á¦6Àå ¼¼°èÀÇ °Ç¿° Ä¡·á ½ÃÀå, Áõ»óº°

Á¦7Àå ¼¼°èÀÇ °Ç¿° Ä¡·á ½ÃÀå, Áö¿ªº°

Á¦8Àå °æÀï »óȲ

Á¦9Àå ±â¾÷ °³¿ä

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global tendonitis treatment market size is expected to reach USD 291.64 billion by 2032, according to a new study by Polaris Market Research. The report "Tendonitis Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment (Therapy and Surgery); By Condition; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising burden of several types of sports-related injuries, constant innovations of new products and technologies, and treatment modalities to offer better treatment facilities with less recovery time, along with the growing efforts undertaken by government organizations worldwide, are among the leading factors driving the market growth. Moreover, the high prevalence of orthopedic procedures, and presence of well-established healthcare infrastructure and treatment facilities, and the implementation of product portfolio expansion by major players, will further stimulate the global market at a significant pace. For instance, in November 2022, Camber Pharmaceuticals added a new product, "Naproxen Oral Suspension." The newly developed product is being indicated to treat the symptoms of tendonitis.

Patients across the globe are increasingly seeking more non-invasive treatment options that offer minimal downtime and faster recovery times, which fuels the demand for therapies such as physical therapy, ultrasound therapy, and shockwave therapy. Additionally, the continuous innovations in tendon replacement and regeneration techniques address the surging demand for alternative engineered tissue and positively influence the market. There has been a significant rise in the penetration for a new kind of treatment, which involves injecting a patient's platelets into the affected tendon to promote healing that can stimulate tissue repair, and the therapy has shown promise in treating tendonitis in the elbow, shoulder, and knee, which is gaining huge popularity and traction all over the world.

Apart from this, with the rapid advances in medical technology, various types of innovative treatment options are available worldwide for tendonitis, including medications, physical therapy, and surgery, which led to increased effectiveness and efficiency of treatment. Despite this, there is an emerging prevalence and awareness regarding the importance of early diagnosis, which creates huge growth opportunities for the market.

Tendonitis Treatment Market Report Highlights

Therapy segment accounted for largest market share in 2022, which is mainly driven by adoption of physical therapy due to its ability to relive patients and its popularity as a cost-efficient option

Golfer's elbow segment is expected to grow at a highest CAGR during the anticipated period, on account of constant changes in people lifestyles and inclination towards sports activity

North America region dominated the global market with maximum share in 2022, owing to increase in people spending capacity, presence of well-developed infrastructure, and high penetration to collaborate with med-tech companies

The global key market players Almatica Pharma, Teva Pharmaceuticals Industries, Abbott Laboratories, Stryker Corporation, Ingelheim Pharmaceuticals, and Zimmer Biomet Holdings

Polaris Market Research has segmented the tendonitis treatment market report based on treatment, condition, and region:

Tendonitis Treatment, Treatment Outlook (Revenue - USD Billion, 2019 - 2032)

Tendonitis Treatment, Condition Outlook (Revenue - USD Billion, 2019 - 2032)

Tendonitis Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Tendonitis Treatment Market Insights

5. Global Tendonitis Treatment Market, by Treatment

6. Global Tendonitis Treatment Market, by Condition

7. Global Tendonitis Treatment Market, by Geography

8. Competitive Landscape

9. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â